company background image
A6X logo

aXichem DB:A6X Stock Report

Last Price

€0.086

Market Cap

€6.7m

7D

8.0%

1Y

-64.3%

Updated

22 Dec, 2024

Data

Company Financials

A6X Stock Overview

A biotechnology company, engages in the development of natural analogue ingredients in Sweden. More details

A6X fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

aXichem AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for aXichem
Historical stock prices
Current Share PriceSEK 0.086
52 Week HighSEK 0.36
52 Week LowSEK 0.056
Beta0.030
1 Month Change40.26%
3 Month Change28.57%
1 Year Change-64.30%
3 Year Change-96.23%
5 Year Change-98.93%
Change since IPO-98.14%

Recent News & Updates

Recent updates

Shareholder Returns

A6XDE ChemicalsDE Market
7D8.0%-3.9%-2.6%
1Y-64.3%-8.9%6.9%

Return vs Industry: A6X underperformed the German Chemicals industry which returned -8.9% over the past year.

Return vs Market: A6X underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is A6X's price volatile compared to industry and market?
A6X volatility
A6X Average Weekly Movement34.3%
Chemicals Industry Average Movement3.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: A6X's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: A6X's weekly volatility has increased from 27% to 34% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19997Torsten Helsingwww.axichem.com

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.

aXichem AB Fundamentals Summary

How do aXichem's earnings and revenue compare to its market cap?
A6X fundamental statistics
Market cap€6.68m
Earnings (TTM)-€1.61m
Revenue (TTM)€647.88k

10.3x

P/S Ratio

-4.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A6X income statement (TTM)
RevenueSEK 7.45m
Cost of RevenueSEK 1.43m
Gross ProfitSEK 6.02m
Other ExpensesSEK 24.58m
Earnings-SEK 18.56m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.31
Gross Margin80.82%
Net Profit Margin-248.98%
Debt/Equity Ratio8.6%

How did A6X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

aXichem AB is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan SvantessonRedeye